Related Tags >> Spiriva Pfizer Atrovent Sales and marketing

Boehringer Ingelheim News

Most Popular Boehringer Ingelheim Story

Pharma sales undergoes major shift

July 15, 2008 — 9:50am ET | By Tracy Staton

Pharma sales forces have been falling under the ax a lot lately. The latest: Boehringer Ingelheim plans to halve its neurology sales force, Pharmalot reports. Some 200 reps will be affected; some may... Read more...

Boehringer Ingelheim Press Releases

Evotec Earns Two Milestone Payments from Boehringer Ingelheim
European CHMP Adopts Negative Opinion on Eli Lilly, Boehringer Ingelheim's Cymbalta for the Treatment of Fibromyalgia
Science survey ranks top biopharma employers
PRESS RELEASE: Boehringer Ingelheim Corporation's Aptivu Capsules Granted Full Approval by the U.S. FDA
PRESS RELEASE: The Lancet publishes major study of Boehringer Ingelheim's novel oral direct thrombin inhibitor dabigatran etexil

Latest Headlines

EU issues Erbitux, Cymbalta decisions
October 24, 2008
Conflicting findings on COPD inhaler
October 8, 2008
Studies link lung meds to stroke, death
September 24, 2008
Boehringer Ingelheim - Top 13 Advertising Budgets
September 23, 2008
Pharma sales undergoes major shift
July 15, 2008
Another gambling addict sues Boehringer
July 10, 2008
Barr closer to launching RLS generic
June 27, 2008

Paid Research Reports